...
首页> 外文期刊>Journal of Bioscience and Bioengineering >Process Standardization for Optimal Virus Recoveryand Removal of Substrate DNA and Bovine Serum Proteins in Vero Cell-Derived Rabies Vaccine
【24h】

Process Standardization for Optimal Virus Recoveryand Removal of Substrate DNA and Bovine Serum Proteins in Vero Cell-Derived Rabies Vaccine

机译:在Vero细胞衍生的狂犬病疫苗中最佳病毒回收和去除底物DNA和牛血清蛋白的过程标准化

获取原文
获取原文并翻译 | 示例

摘要

Purification of a rabies vaccine by a single zonal centrifugation run was replaced by two runs with optimal standization of the sucrose density gradient. As a result, significant reductions in the levels of substrate DNA and bovine serum protein in the Vero cell-derived human rabies vaccine were achieved. Following many trials, for the first run, loading of the 3.2-l capacity K-3 rotor with 1800 ml of 60% sucrose solution and 1400 ml of vaccine PBS buffer solution gave a satisfactory linear gradient. However, after the first run, the substrate DNA and bovine serum contents exceeded the required levels. After protamine sulphate and Tween-80 treatment of the concentrated inactivated material, a second run using the same procedure as in the first run was tried. However, these purification procedures resulted in low virus recovery. To achieve optimal virus recovery, and removal of substrate DNA and bovine serum protein, the peak fractions from the first run as indicated by the haemagglutination, sucrose concentration, and optical density values were pooled and the sucrose concentration of the pooled fractions was increased to 60%. A second (flotation) run was then carried out. Using this method, the virus recovery rate was more than 95% that of the first run, and the levels of cellular DNA and bovine serum protein were well within the acceptable limits of less than 100 pg/dose and one part per million, respectively. The substrate DNA was quantified by both radioactive labeling and non-radioactive biotin labeling methods. For the quantification of calf serum protein, a counter-immunoelectrophoressi method was developed and effectively applied. A potency assay was performed using the National Institutes of Health (NIH) and well-standardized in vitro single radial immuno diffusion (SRD) methods. Finally, an immunogenicity study was conducted with human volunteers and the results were confirmed by a rapid fluorescent focus inhibition test (RFFIT).
机译:通过单次分区离心纯化狂犬病疫苗的方法被两次蔗糖密度梯度最佳保持的方法取代。结果,在源自Vero细胞的人狂犬病疫苗中,底物DNA和牛血清蛋白水平显着降低。经过多次试验后,对于第一次运行,在1800 ml 60%蔗糖溶液和1400 ml疫苗PBS缓冲溶液中装入3.2-l容量的K-3转子时,线性梯度令人满意。但是,第一次运行后,底物DNA和牛血清含量超过了所需水平。在硫酸鱼精蛋白和浓缩的灭活材料的吐温80处理之后,尝试使用与第一次试验相同的方法进行第二次试验。但是,这些纯化步骤导致病毒回收率低。为了获得最佳的病毒回收率,并去除底物DNA和牛血清蛋白,如血球凝集,蔗糖浓度和光密度值所示,将第一次运行的峰级分合并,合并级分的蔗糖浓度增加至60 %。然后进行第二次浮选。使用这种方法,病毒的回收率比第一次试验高出95%,并且细胞DNA和牛血清蛋白的水平分别在可接受的范围内,分别小于100 pg /剂量和百万分之一。通过放射性标记和非放射性生物素标记方法定量底物DNA。为了量化小牛血清蛋白,开发了一种抗免疫电泳方法并有效地应用了它。使用国立卫生研究院(NIH)和标准化良好的体外单放射免疫扩散(SRD)方法进行效能测定。最后,对人类志愿者进行了免疫原性研究,结果通过快速荧光聚焦抑制试验(RFFIT)得以证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号